CompletedNot Applicable

Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer

Australia761 participantsStarted 2008-06

Plain-language summary

This project will conduct a prospective, longitudinal, observational cohort study to assess the onset and incidence of lymphoedema, as well as investigate factors associated with its development among women newly diagnosed with gynaecological cancers in 2008 to 2011.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for surgery of benign or malignant gynaecological diseases as determined jointly by the surgeon and the patient. * Non-pregnant female patients. * Over 18 years of age at time of surgery. * Patients who understand the conditions of the study and are willing to participate for the length of the prescribed term of follow-up. * Patients who are capable of, and have given, informed consent to their participation in the study. Exclusion Criteria: * Patients with a pacemaker. * Allergies against adhesive electrodes and extensive internal metal plates are ineligible for BIS measurement.

What they're measuring

Time of onset of lymphoedema after gynaecological cancer treatment.

Timeframe: 2 years

Incidence of lymphoedema after gynaecological cancer treatment.

Timeframe: 2 years

Point prevalence of lymphoedema after gynaecological cancer treatment.

Timeframe: 2 years

Severity of lymphoedema after gynaecological cancer treatment.

Timeframe: 2 years

Trial details

NCT IDNCT00604994

SponsorQueensland Centre for Gynaecological Cancer

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2013-01

View on ClinicalTrials.gov More Female Genital Diseases trials